首页|艾司氯胺酮复合罗哌卡因在臂丛神经阻滞的应用

艾司氯胺酮复合罗哌卡因在臂丛神经阻滞的应用

Application of esketamine combined with ropivacaine in brachial plexus block

扫码查看
目的 探讨艾司氯胺酮复合罗哌卡因在臂丛神经阻滞中的应用效果.方法 159例行上肢骨折切开复位内固定术患者随机分为三组,每组53例.H组采用0.4%罗哌卡因+艾司氯胺酮0.5 mg/kg共40 mL,L组采用0.4%罗哌卡因+艾司氯胺酮0.1 mg/kg共40 mL,C组仅采用0.4%罗哌卡因40 mL.比较三组感觉阻滞和运动阻滞起效时间及持续时间.记录患者进入手术室(T0)、神经阻滞后15 min(T1)和神经阻滞后30 min(T2)时的MAP和HR.比较三组术后24 h运动数字分级评分法(NRS)评分、抑郁自评量表(SDS)评分和术后24 h内曲马多补救镇痛使用情况及不良反应发生情况.结果 H组感觉阻滞起效时间短于L、C组(P<0.05).H组感觉阻滞持续时间长于L、C组(P<0.05),且L组亦长于C组(P<0.05).H、L组运动阻滞持续时间长于C组(P<0.05).H、L组术后24 h SDS评分和NRS评分均低于C组(P<0.05).三组患者T0~T2时MAP、HR比较差异均无统计学意义(P>0.05).术后24 h内,H、L组曲马多补救镇痛使用比例少于C组(P<0.05),三组不良反应的发生率比较差异无统计学意义(P>0.05).结论 艾司氯胺酮复合罗哌卡因用于臂丛神经阻滞可延长镇痛持续的时间,提高镇痛效果,减少术后阿片类药物的使用,不增加不良反应,并降低患者术后抑郁的发生率.
Objective To explore the application efficacy of esketamine combined with ropivacaine in brachial plexus block.Methods A total of 159 patients who underwent open reduction and internal fixation for upper limb fractures were divided into three groups with 53 cases each.Group H received 0.4%ropivacaine plus esketamine 0.5 mg/kg total 40 mL,group L received 0.4%ropivacaine plus esketamine 0.1 mg/kg total 40 mL,and group C received only 0.4%ropivacaine 40 mL.The onset time and duration of sensory blockade and motor blockade were compared among the three groups.MAP and HR were recorded at the time of entering the operating room(T0),15 minutes(T1)and 30 minutes after nerve block(T2).The NRS score and SDS score at 24 hours postoperatively,the use of tramadol for analgesia and the occurrence of adverse reactions within 24 hours after operation were compared among the three groups.Results The onset time of sensory blockade in group H was shorter than that in groups of L and C(P<0.05).The duration of sensory blockade in group H was longer than that in groups of L and C(P<0.05),which was also longer in group L than that in group C(P<0.05).The duration of motor blockade in groups of H and L was longer than that in group C(P<0.05).The SDS score and NRS score at 24 hours after surgery in groups of L and H were lower than those in group C(P<0.05).There were no statistical differences in MAP and HR among the three groups at T0-T2(P>0.05).Within 24 hours after surgery,the proportion of tramadol used for analgesia in groups of H and L was lower than that in group C(P<0.05).There was no statistical difference in the incidence of adverse reactions among the three groups(P>0.05).Conclusion Combined use of esketamine and ropivacaine for brachial plexus block can prolong the duration of pain relief,improve the analgesic efficacy,reduce the use of postoperative opioid drugs,not increase adverse reactions,and decrease the incidence of postoperative depression.

Brachial plexus blockEsketamineRopivacainePostoperative analgesia

张凯、罗兴均、王甲高、郑敏

展开 >

442000 湖北十堰,湖北医药学院附属人民医院麻醉科

臂丛神经阻滞 艾司氯胺酮 罗哌卡因 术后镇痛

十堰市引导性科研项目

22Y64

2024

江苏医药
江苏省人民医院(南京医科大学第一附属医院)

江苏医药

影响因子:0.707
ISSN:0253-3685
年,卷(期):2024.50(6)